Krisztina Herédi‐Szabó

Author

Also Known As

K Herédi-Szabó, K. Herédi-Szabó, Krisztina Heredi-Szabo, Krisztina Heredi‐Szabo, Krisztina Herédi-Szabó, Krisztina Herédi‐Szabó

Publications

980

Citations

H-Index

Concepts

All Affiliations

Solvo Biotechnology (Hungary)University of Szeged Creighton University Drexel University BD Biosciences (United States)

About

Krisztina Herédi‐Szabó is an author at Solvo Biotechnology (Hungary) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	147
2	Biochemistry	5	5	130
3	Natural Sciences	2	2	40
4	Health Sciences	1	1	43
5	Cellular Physiology	1	1	18

Krisztina Herédi‐Szabó

Publications

668

Citations

H-Index

Page 1

	Year	Citations
Variability in P-Glycoprotein Inhibitory Potency (IC50) Using Various in Vitro Experimental Systems: Implications for Universal Digoxin Drug-Drug Interaction Risk Assessment Decision Criteria Joe Bentz, Michael O′Connor, Dallas Bednarczyk, Drug Metabolism and Disposition	2013	147
Effect of Membrane Cholesterol on BSEP/Bsep Activity: Species Specificity Studies for Substrates and Inhibitors Emese Kis, Enikő Ioja, Tünde Nagy, Drug Metabolism and Disposition	2009	94
Leflunomide and its metabolite A771726 are high affinity substrates of BCRP: implications for drug resistance E. Kis, Tünde Nagy, Marghi Jani, Annals of the Rheumatic Diseases	2008	73
Characterization of 5(6)-Carboxy-2,′7′-Dichlorofluorescein Transport by MRP2 and Utilization of this Substrate as a Fluorescent Surrogate for LTC4 Krisztina Herédi‐Szabó, Emese Kis, E. M. Molnar, SLAS DISCOVERY	2008	43
Quantitative Systems Toxicology Analysis of<i>In Vitro</i>Mechanistic Assays Reveals Importance of Bile Acid Accumulation and Mitochondrial Dysfunction in TAK-875-Induced Liver Injury Diane Longo, Jeffrey L. Woodhead, Paul Walker, Toxicological Sciences Mitochondrial DysfunctionPathologyCholangiopathiesQuantitative Systems ToxicologyPhysiologically-based Pharmacokinetic Modeling	2018	43
Application of Receiver Operating Characteristic Analysis to Refine the Prediction of Potential Digoxin Drug Interactions Harma Ellens, Shibing Deng, JoAnn Coleman, Drug Metabolism and Disposition	2013	42
A P-gp vesicular transport inhibition assay – Optimization and validation for drug–drug interaction testing Krisztina Herédi‐Szabó, Johan Palm, Tommy B. Andersson, European Journal of Pharmaceutical Sciences Pharmaceutical ScienceDrug TargetDrug–drug InteractionBiochemistryMedicine	2013	36
Multidrug Resistance Protein 2-Mediated Estradiol-17β-d-glucuronide Transport Potentiation: In Vitro-in Vivo Correlation and Species Specificity Krisztina Herédi‐Szabó, Hristos Glavinas, E. Kis, Drug Metabolism and Disposition	2009	32
Quinidine as an ABCB1 Probe for Testing Drug Interactions at the Blood–Brain Barrier: An In Vitro In Vivo Correlation Study Istvan Sziráki, Franciska Erdő, Erzsébet Beéry, SLAS DISCOVERY	2011	30
High and low affinity receptors mediate growth effects of gastrin and gastrin‐Gly on DLD‐1 human colonic carcinoma cells Shawn Ahmed, Barna Budai, Krisztina Herédi‐Szabó, FEBS Letters	2003	24

Page 1